TY  - JOUR
AU  - Hidalgo-Tenorio, Carmen
AU  - Ramírez-Taboada, Jessica
AU  - Gil-Anguita, Concepción
AU  - Esquivias, Javier
AU  - Omar-Mohamed-Balgahata, Mohamed
AU  - SamPedro, Antonio
AU  - Lopez-Ruz, Miguel
AU  - Pasquau, Juan
PY  - 2017
DO  - 10.1186/s12981-017-0160-0
UR  - https://hdl.handle.net/10668/27770
T2  - AIDS research and therapy
AB  - Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine were evaluated in HIV-positive Spanish MSM. The prevalence of High Squamous Intraepithelial Lesions (HSIL) and genotypes of high-risk human papillomavirus (HR-HPV) were...
LA  - en
KW  - Anal cancer
KW  - High squamous intra-epithelial lesions (HSIL)
KW  - Human immunodeficiency virus (HIV)
KW  - Low squamous intra-epithelial lesion (LSIL)
KW  - Men having sex with men (MSM)
KW  - Quadrivalent HPV vaccine
KW  - Adult
KW  - Anal Canal
KW  - Antibodies, Viral
KW  - Anus Neoplasms
KW  - CD4 Lymphocyte Count
KW  - Coinfection
KW  - Double-Blind Method
KW  - HIV Infections
KW  - Homosexuality, Male
KW  - Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
KW  - Human papillomavirus 16
KW  - Human papillomavirus 18
KW  - Humans
KW  - Male
KW  - Papillomavirus Infections
KW  - Placebos
KW  - Spain
KW  - Viral Load
KW  - Viremia
TI  - Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM).
TY  - research article
VL  - 14
ER  -